Clinicians & Researchers
You are here
PETAL Network Bibliography
Export 63 results:
Author Title Type [ Year
Filters: First Letter Of Last Name is C [Clear All Filters]
Assessment of Symptom, Disability, and Financial Trajectories in Patients Hospitalized for COVID-19 at 6 Months.. JAMA Netw Open. 6(2):e2255795.
.
2023. Assessment of Symptom, Disability, and Financial Trajectories in Patients Hospitalized for COVID-19 at 6 Months.. JAMA Netw Open. 6(2):e2255795.
.
2023. Effect of P2Y12 Inhibitors on Organ Support-Free Survival in Critically Ill Patients Hospitalized for COVID-19: A Randomized Clinical Trial.. JAMA Netw Open. 6(5):e2314428.
.
2023. Effect of P2Y12 Inhibitors on Organ Support-Free Survival in Critically Ill Patients Hospitalized for COVID-19: A Randomized Clinical Trial.. JAMA Netw Open. 6(5):e2314428.
.
2023. Renin-Angiotensin System Modulation With Synthetic Angiotensin (1-7) and Angiotensin II Type 1 Receptor-Biased Ligand in Adults With COVID-19: Two Randomized Clinical Trials.. JAMA. 329(14):1170-1182.
.
2023. Renin-Angiotensin System Modulation With Synthetic Angiotensin (1-7) and Angiotensin II Type 1 Receptor-Biased Ligand in Adults With COVID-19: Two Randomized Clinical Trials.. JAMA. 329(14):1170-1182.
.
2023. Research Staff COVID-19 Pandemic Survey-Results from the Prevention and Early Treatment of Acute Lung Injury (PETAL) Network. COVID and Post-COVID: The Psychological and Social Impact of COVID-19. 3:1528-1543.
.
2023. Characteristics and Outcomes of US Patients Hospitalized With COVID-19. Am J Crit Care. 31(2):146-157.
.
2022. Characteristics and Outcomes of US Patients Hospitalized With COVID-19. Am J Crit Care. 31(2):146-157.
.
2022. Effect of P2Y12 Inhibitors on Survival Free of Organ Support Among Non-Critically Ill Hospitalized Patients With COVID-19: A Randomized Clinical Trial.. JAMA. 327(3):227-236.
.
2022. Effect of P2Y12 Inhibitors on Survival Free of Organ Support Among Non-Critically Ill Hospitalized Patients With COVID-19: A Randomized Clinical Trial.. JAMA. 327(3):227-236.
.
2022. Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19 : A Randomized Controlled Trial.. Ann Intern Med. 175(9):1266-1274.
.
2022. Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19 : A Randomized Controlled Trial.. Ann Intern Med. 175(9):1266-1274.
.
2022. Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19 : A Randomized Controlled Trial.. Ann Intern Med. 175(9):1266-1274.
.
2022. Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19 : A Randomized Controlled Trial.. Ann Intern Med. 175(9):1266-1274.
.
2022. .
2022. Characteristics and Outcomes of US Patients Hospitalized With COVID-19. American Journal of Critical Care.
.
2021. Characteristics and Outcomes of US Patients Hospitalized With COVID-19. American Journal of Critical Care.
.
2021. .
2021. Effect of Early High-Dose Vitamin D3 Repletion on Cognitive Outcomes in Critically Ill Adults.. Chest. 160(3):909-918.
.
2021. A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19.. N Engl J Med. 384(10):905-914.
.
2021. A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19.. N Engl J Med. 384(10):905-914.
.
2021. Recall of clinical trial participation and attrition rates in survivors of acute respiratory distress syndrome.. J Crit Care. 64:160-164.
.
2021. Recall of clinical trial participation and attrition rates in survivors of acute respiratory distress syndrome.. J Crit Care. 64:160-164.
.
2021. Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19.. N Engl J Med. 385(9):777-789.
.
2021. Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19.. N Engl J Med. 385(9):777-789.
.
2021. Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19.. N Engl J Med. 385(9):777-789.
.
2021. Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19.. N Engl J Med. 385(9):777-789.
.
2021. Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19.. N Engl J Med. 385(9):777-789.
.
2021. Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19.. N Engl J Med. 385(9):777-789.
.
2021. Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19.. N Engl J Med. 385(9):777-789.
.
2021. Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19.. N Engl J Med. 385(9):777-789.
.
2021. Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19.. N Engl J Med. 385(9):777-789.
.
2021. Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19.. N Engl J Med. 385(9):777-789.
.
2021. Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.. N Engl J Med. 385(9):790-802.
.
2021. Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.. N Engl J Med. 385(9):790-802.
.
2021. Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.. N Engl J Med. 385(9):790-802.
.
2021. Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.. N Engl J Med. 385(9):790-802.
.
2021. Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.. N Engl J Med. 385(9):790-802.
.
2021. Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.. N Engl J Med. 385(9):790-802.
.
2021. Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.. N Engl J Med. 385(9):790-802.
.
2021. Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.. N Engl J Med. 385(9):790-802.
.
2021. Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.. N Engl J Med. 385(9):790-802.
.
2021. Variation in Initial U.S. Hospital Responses to the Coronavirus Disease 2019 Pandemic . Critical Care Medicine.
.
2021. .
2020. .
2020. .
2020.
Monitoring Research Blood Sampling in Critically Ill Patients: Avoiding Iatrogenic Anemia.. Am J Respir Crit Care Med. 202(6):885-887.
.
2020. Rationale and Design of ORCHID: A Randomized Placebo-controlled Clinical Trial of Hydroxychloroquine for Adults Hospitalized with COVID-19.. Ann Am Thorac Soc. 17(9):1144-1153.
.
2020. Rationale and Design of ORCHID: A Randomized Placebo-controlled Clinical Trial of Hydroxychloroquine for Adults Hospitalized with COVID-19.. Ann Am Thorac Soc. 17(9):1144-1153.
.
2020.